Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars

• Status: Completed
• Trial end date: 2012-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the efficacy and safety of Adapalene Gel 0.3% in the treatment of atrophic acne scars.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Galderma; Galderma R&D
• Treatments: Adapalene

Criteria

Inclusion Criteria:

• Male or female subjects of any race, aged 18 to 50 years inclusive

• Subjects with a past history of acne and with moderate to severe facial atrophic acne scars

Exclusion Criteria:

• Subjects with active inflammatory acne lesions

• Subjects with hypertrophic acne scars